Consonance Capital Management’s Karyopharm Therapeutics KPTI Stock Holding History

Consonance Capital Management’s Portfolio KPTI Stock Details KPTI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-432,787	Closed	-$123M	–	33
2020 Q2	$123M	Sell	432,787 -45,926	-10%	-$13.6M	7.37%	2
2020 Q1	$138M	Buy	478,713 +70,217	+17%	+$19.4M	10.27%	1
2019 Q4	$117M	Buy	408,496 +19,334	+5%	+$4.19M	7.17%	3
2019 Q3	$56.2M	Buy	389,162 +2,280	+0.6%	+$309K	5.56%	7
2019 Q2	$34.8M	Buy	386,882 +42,956	+12%	+$3.45M	2.46%	15
2019 Q1	$30.1M	Buy	343,926 +23,254	+7%	+$2.58M	1.9%	17
2018 Q4	$45.1M	Sell	320,672 -1,133	-0.4%	-$191K	3.31%	13
2018 Q3	$82.2M	Buy	321,805 +4,000	+1%	+$1.11M	4.43%	8
2018 Q2	$81M	Buy	+317,805	New	+$78.6M	5.22%	6

Other funds holding KPTI

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Adage Capital Partners

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return

Alkeon Capital Management

Alkeon Capital Management New York $22.1B AUM 51.63% 1-Year Est. Return

Wellington Management Group

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return